You are here

Article info

Article menu

Download PDFPDF

XML
Case report
Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease

Authors

  • Thanh Duc Hoang Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USAMedicine, Uniformed Services University of the Health Sciences F Edward Hebert School of Medicine, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Nguyen T Nguyen Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Eva Chou Ophthalmology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  • Mohamed KM Shakir Endocrinology, Walter Reed National Military Medical Center, Bethesda, Maryland, USAMedicine, Uniformed Services University of the Health Sciences F Edward Hebert School of Medicine, Bethesda, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Thanh Duc Hoang; tdhdthanh{at}gmail.com
View Full Text

Citation

Hoang TD, Nguyen NT, Chou E, et al
Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease
BMJ Case Reports CP 2021;14:e242153.

Publication history

  • Accepted April 17, 2021
  • First published May 10, 2021.
Online issue publication 
January 24, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.